|
|
| Quarterly Results |
|
| Dishman Carbogen Amcis Ltd | | Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln | Chairman : Janmejay R Vyas | | Home : Indian Private | Book Value: 261.2390461 | | BSE Code : 540701 | Market Cap: 3642.07 | | NSE Code : DCAL | P / E : 0 | |
| |
|
|
|
|
|
|
| (Rs in Cr.) |
|
|
| Type | 3Qtr | 2Qtr | 1Qtr | 4Qtr | | Net Sales | 86.82 | 59.72 | 69.55 | 113.13 | | Other Income | 13.11 | 38.71 | 14.44 | 14.79 | | Total Income | 99.93 | 98.43 | 83.99 | 127.92 | | Total Expenditure | 83.65 | 65.69 | 74.57 | 106.78 | | Operating Profit | 16.28 | 32.74 | 9.42 | 21.14 | | Interest | 17.14 | 17.42 | 17.76 | 17.03 | | Gross Profit | -0.86 | 15.32 | -8.34 | 4.11 | | Depreciation | 26.22 | 24.58 | 24.69 | 23.45 | | Tax | 0.00 | 0.00 | 0.00 | 0.00 | | Deferred Tax | -8.90 | -3.48 | -11.70 | -9.11 | | Reported Profit After Tax | -18.18 | -5.78 | -21.33 | -10.23 |
|
|
|
|
|